LivaNova Sorin Mitroflow Aortic Pericardial Heart Valve

Country: Singapore

Language: English

Source: HSA (Health Sciences Authority)

Available from:

LIVANOVA SINGAPORE PTE. LTD.

Class:

Class D medical device

Manufactured by:

LivaNova Canada Corp.

Therapeutic area:

Cardiovascular

Therapeutic indications:

The Mitroflow valve is intended for the replacement of malfunctioning native or prosthetic aortic valves. The Mitroflow valve is suggested for use in those patients where long-term anticoagulation therapy may be undesirable for a variety of reasons, such as patients living in remote areas, patients with gastrointestinal or other bleeding problems, patients who may be expected to undergo other surgery, elderly patients and others where difficulty may be expected with anticoagulants, for social, or other medical reasons.

Product summary:

Device System Info:[Sterile Medical Device], iv) steam sterilisation (jar), liquid chemical sterilant process (valve); Models: Sorin Mitroflow Aortic Pericardial Heart Valve - LXA19, Sorin Mitroflow Aortic Pericardial Heart Valve - LXA21, Sorin Mitroflow Aortic Pericardial Heart Valve - LXA23, Sorin Mitroflow Aortic Pericardial Heart Valve - LXA25, Sorin Mitroflow Aortic Pericardial Heart Valve - LXA27, Sorin Mitroflow Aortic Pericardial Heart Valve - DLA19, Sorin Mitroflow Aortic Pericardial Heart Valve - DLA21, Sorin Mitroflow Aortic Pericardial Heart Valve - DLA23, Sorin Mitroflow Aortic Pericardial Heart Valve - DLA25, Sorin Mitroflow Aortic Pericardial Heart Valve - DLA27, Sorin Mitroflow Aortic Pericardial Heart Valve - DLA29

Authorization date:

2011-12-22